Skip to main content
Home
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH

Pancreatitis

19-08-2021 | Pancreatitis | News

Postpancreatitis diabetes commonly misclassified and unsuitably treated

Postpancreatitis diabetes mellitus is under-recognized and often misclassified as type 2 diabetes, which can result in improper treatment, population-based study data show.

28-09-2016 | Pancreatitis | News | Article

Pancreatitis risk small but real with gliptin treatment

A meta-analysis of randomised trials indicates that gliptin treatment is associated with a small but significantly increased risk of acute pancreatitis among patients with Type 2 diabetes.